Skip to content

intravenous thrombolysis with urokinase acute ischaemic stroke

intravenous thrombolysis with urokinase acute ischaemic stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-17012596
Enrollment
Unknown
Registered
2017-09-06
Start date
2017-07-19
Completion date
Unknown
Last updated
2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischaemic stroke

Interventions

Case series:Nil

Sponsors

First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Aged = 18 years; 2. ischemic stroke diagnosed by CT or MRI; 3. first stroke onset or past stroke without obvious neurological deficit (mRS=1); 4. Time from onset to treatment: < 6 hours; 5. Treatment with intravenous urokinase; 6. Signed informed consent by patient self or legally authorized representatives.

Exclusion criteria

Exclusion criteria: 1. Suspected subarachnoid hemorrhage, intracranial hemorrhage and hemorrhagic cerebral infarction; 2. Severe systemic disease which is expected to survive less than 3 months; 3. Major surgery within 1 month; 4. Uncontrolled hypertension (>180/100 mmHg); 5. Platelet count <10×10^9/L.

Design outcomes

Primary

MeasureTime frame
the bather index at 3 months;MRS at 3 months;

Countries

China

Contacts

Public ContactQin Xinyue

First Affiliated Hospital of Chongqing Medical University

qinxy2011@sina.com+86 15320461411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026